Literature DB >> 19297283

Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.

R Fanci1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297283     DOI: 10.1179/joc.2009.21.1.105

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


× No keyword cloud information.
  5 in total

1.  In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

Authors:  Arjuna Nishantha Bandara Ellepola; Ranil Samantha Dassanayake; Ziauddin Khan
Journal:  Med Princ Pract       Date:  2019-06-28       Impact factor: 1.927

2.  Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.

Authors:  Marçal Mariné; F Javier Pastor; Ismail H Sahand; José Pontón; Guillermo Quindós; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

3.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

4.  In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species.

Authors:  Arjuna N B Ellepola; Rachel Chandy; Zia U Khan
Journal:  Med Princ Pract       Date:  2016-04-23       Impact factor: 1.927

5.  Purpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilms.

Authors:  Paul Wai-Kei Tsang; Alan Pak-Kin Wong; Hai-Ping Yang; Ngai-For Li
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.